Optimal utilisation of biologic drugs in Behçet’s Disease: a randomised controlled trial of infliximab (IFX) verses alphainterferon (aIFN), with genotyping and metabolomic profiling, towards a stratified medicines approach to treatment. - BIO BEHÇET’S Optimal utilisation of biologic drugs in Behçet’s Disease: a randomised controlled trial of inflixim ...
Low Dose InterferonAlpha Treatment for Oral Ulcers of Behcet's Disease
Phase II Study, Evaluation of Low Dose Natural Human InterferonAlpha Administered by the Oral Mucosal Route in the Treatment of Behçet's Disease Phase II Study, Evaluation of Low Dose Natural Human InterferonAlphaAdministered by the Oral Mucosa ...
Interferon-alpha2a Versus Cyclosporin A for Severe Ocular Behcet's Disease (INCYTOB)
Phase III Study of Recombinant Human Interferon-alpha2a Versus Cyclosporin A for the Treatment of Ocular Behcet's Disease - a National,Randomised, Single-masked Controlled Trial (INCYTOB) Phase III Study of Recombinant Human Interferon-alpha2a Versus Cyclosporin A for the Treatment of Oc ...